Headlines
- Second quarter 2026 results summary. During Q2 2026, T1 achieved total net sales of
$250.1 million , G1_Dallas module production of 935 MW, a net loss from continuing operations of$(36.9) million , and Adjusted EBITDA of$10.7 million . The Company’s second quarter 2026 net loss from continuing operations and Adjusted EBITDA included a pre-tax reduction in Cost of Sales due to$24.4 million of tariff refunds recognized during the quarter. - T1 and Clearway execute strategic offtake deal. In
August 2026 , T1 announced a contract to supply independent power producerClearway Energy Group (“Clearway”) 641 MW of solar modules built with domestic cells from T1’s G2_Austin solar cell fab. This latest offtake contract marks a continuation of T1’s commercial strategy to offer customers a traceable and reliable solar supply chain built on leadingU.S . technology and domestic content. - T1 acquires advanced solar intellectual property rights from Evervolt. In
July 2026 , the Company announced that it acquired foundational solar patents and other intellectual property rights fromEvervolt Green Energy Holding Pte Ltd. (“Evervolt”) for total consideration of$135 million . T1 believes these patents, which relate to Tunnel Oxide Passivated Contact (“TOPCon”) solar cells and modules, provide the most advanced, highly efficient commercially viable solar technology available. - G2_Austin project update. Construction work on the 2.1 GW Phase 1 of G2_Austin, T1’s solar cell fab, continues with the building ready for interior Mechanical, Electrical and Plumbing installation. Additionally, T1 has begun receiving the first containers of production line equipment at
U.S . ports, and all the key shipments from T1’s production line equipment vendor for Phase 1 are now either on the water or already inthe United States . Long lead time clean room equipment has also been ordered ahead of the projected start of clean room installation later in the third quarter. As the Company indicated in July, T1 is projecting that capital expenditures for G2_Austin Phase 1 will total$510 million in accordance with the recent addition of a 20% contingency. The capital expenditure contingency is intended to account for labor and materials costs associated with tightness in theTexas data center construction market. T1 expects to produce the first solar cells at G2_Austin in Q1 2027. - T1 applauds the Section 232 proclamation in support of American polysilicon solar manufacturing. The Company believes the new action, which was signed and announced on
August 6, 2026 , aligns with T1’s strategy to build a vertically integrated solar supply chain on industry leadingU.S . technology. The proclamation details new tariffs onU.S . imports of polysilicon and polysilicon derivatives, which go into effect onDecember 4, 2026 . It also launches an onshoring program to incentivize companies to invest inU.S . production of polysilicon products. T1 plans to work with theDepartment of Commerce to access the tariff offset onshoring program through T1’s committed and planned investments in G2_Austin, TOPCon IP, andU.S . polysilicon and wafer commitments withHemlock Semiconductor and Corning, Inc. (NYSE: GLW).
“We made significant advances during and since the second quarter to strengthen T1’s long-term competitive position while we fund and execute our domestic vertical integration strategy,” said
Business update and guidance
- Nordic value optimization. T1 is engaged in discussions with multiple parties to explore potential strategic pathways to generate value from the Company’s Nordic portfolio. T1’s Nordic data center asset, which has been assigned a 50 MW grid allocation by Norway’s power grid operator, remains in the queue for 396 MW of power. Potential monetization structures could include participation in a joint venture through T1’s contribution of assets with established operators in the global data center ecosystem.
- Section 45X tax credits. During Q2 2026, T1 monetized the balance of the Company's remaining 2025 Section 45X tax credits (as defined below) for
$39.1 million , at a gross price of$0.93 on the dollar, which was higher than previously announced 2025 sales. T1 has also commenced early-stage negotiations with several potential counterparties regarding sales of Section 45X tax credits accrued in 2026. - Enhanced full-year 2026 G1_Dallas production target. T1 expects the run rate of production in Q3 and Q4 2026 will exceed Q2 2026 production and believes 2026 production will fall within the higher end of its previously disclosed 2026 production range of 3.1 - 4.2 GW. The enhanced production target reflects T1's progress qualifying international cell vendors to supply G1_Dallas.
- Financing update. T1 continues to target a comprehensive financing solution, which includes a significant debt component, in an amount sufficient to fund the remaining estimated capital expenditure required for G2_Austin Phase 1.
Subsequent Events to Q2 2026
- T1 completed a private placement of
$120 million of convertible senior notes due 2031. InJuly 2026 , the Company completed a private placement of$120 million aggregate principal amount of its 4.75% convertible senior notes due 2031. The offering generated gross proceeds of$120 million and is intended as a bridge to a comprehensive financing solution to fund the remaining capital expenditures of the 2.1 GW Phase 1 of G2_Austin. - T1 closes acquisition of
KORE Power, Inc. , creating T1 NRI brand to service BESS and data center infrastructure markets. InJuly 2026 , T1 closed the previously announced acquisition ofKORE Power, Inc. The transaction is expected to provide T1 with an entry point into the energy storage and AI data center infrastructure markets through an expanded potential customer base for solar and storage solutions.
Q2 2026 Results Overview
T1 Energy reported a net loss attributable to common stockholders for the second quarter of 2026 of$44.5 million , or$(0.16) per share compared to a net loss of$32.8 million , or$(0.21) per share for the second quarter of 2025. Net loss from continuing operations was$36.9 million , or$(0.14) per share for the second quarter of 2026 compared to a net loss from continuing operations of$31.2 million , or$(0.21) per share for the second quarter of 2025. Net loss from discontinued operations was$6.6 million , or$(0.02) per share for the second quarter of 2026 compared to a net loss of$0.7 million , or$(0.00) per share for the second quarter of 2025.- As of
June 30, 2026 , T1 had cash, cash equivalents, and restricted cash of$156.4 million , of which$79.1 million was unrestricted cash.
Presentation of Second Quarter 2026 Results
A presentation will be held today,
Participants can access the conference call by clicking the following link and completing the online registration form. Upon registering participants will receive the dial-in info and PIN to join the call.
The call will also be available by clicking the webcast link.
About
To learn more about T1, please visit www.T1energy.com and follow on social media.
Investor contact:
EVP, Investor Relations and Corporate Development
jeffrey.spittel@T1energy.com
Tel: +1 409 599-5706
Media contact:
EVP,
russell.gold@T1energy.com
Tel: +1 214 616-9715
Cautionary Statement Concerning Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation with respect to T1’s strategy of developing as an integrated
The above referenced filings are available on the SEC’s website at www.sec.gov. Forward-looking statements speak only as of the date of this press release and are based on information available to T1 as of the date of this press release, and T1 assumes no obligation to update such forward-looking statements, all of which are expressly qualified by the statements in this section, whether as a result of new information, future events or otherwise, except as required by law.
T1 intends to use its website as a channel of distribution to disclose information which may be of interest or material to investors and to communicate with investors and the public. Such disclosures will be included on T1’s website in the ‘Investor Relations’ section. T1, and its CEO and Chairman of the Board,
Use of Non-GAAP Financial Measures
T1 reports financial results in accordance with generally accepted accounting principles in
T1 defines Adjusted EBITDA as net income (loss) from continuing operations before interest expense, income tax expense (benefit), depreciation and amortization, and further adjusted to exclude certain items that management does not consider indicative of the Company’s core operating performance, including, but not limited to, non-cash charges, non-recurring items, and non-operating gains or losses. These adjustments include impairment charges, losses on debt extinguishment, losses on settlement of derivative liabilities, share-based compensation, fair value adjustments of warrant and derivative liabilities, and non-recurring transaction expenses. Our Adjusted EBITDA measure was re-defined in the fourth quarter of 2025 to also exclude certain non-recurring transaction expenses. The historical presentation of Adjusted EBITDA in this press release has been recast to conform to the revised definition.
T1 uses Adjusted EBITDA as a key measure in evaluating its financial and operating performance and in making strategic business decisions. T1 believes that Adjusted EBITDA, when considered together with the corresponding GAAP financial measures, provides meaningful supplemental information by excluding items that may not be representative of its core business, operating results, or future outlook. However, Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as an alternative to net income (loss) from continuing operations or any other measure of performance or liquidity presented in accordance with GAAP.
Adjusted EBITDA has been reconciled to the nearest GAAP measure for historical periods in the table entitled “Reconciliation of Non-GAAP Measures to Most Comparable Amounts” set forth on Annex A of this press release.
CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except per share amounts) (Unaudited) | ||||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 79,109 | $ | 182,450 | ||||
| Restricted cash | 70,207 | 81,203 | ||||||
| Accounts receivable trade, net - related parties | 98,645 | 84,481 | ||||||
| Government grants receivable, net | 95,390 | 36,376 | ||||||
| Inventory | 228,773 | 116,043 | ||||||
| Advances to suppliers | 133,231 | 137,532 | ||||||
| Other current assets | 38,611 | 5,989 | ||||||
| Current assets of discontinued operations | 7,229 | 19,418 | ||||||
| Total current assets | 751,195 | 663,492 | ||||||
| Restricted cash | 7,120 | 7,120 | ||||||
| Property and equipment, net | 430,416 | 302,302 | ||||||
| 57,449 | 57,449 | |||||||
| Intangible assets, net | 157,781 | 180,481 | ||||||
| Right-of-use asset under operating leases | 218,320 | 151,166 | ||||||
| Other assets | 19,988 | 10,098 | ||||||
| Total assets | $ | 1,642,269 | $ | 1,372,108 | ||||
| LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 102,282 | $ | 91,323 | ||||
| Accrued liabilities and other | 86,085 | 47,224 | ||||||
| Deferred revenue | 150,398 | 56,731 | ||||||
| Derivative liabilities | 1,352 | 11,661 | ||||||
| Current portion of long-term debt | 49,593 | 46,357 | ||||||
| Accounts payable and accrued liabilities - related parties | 125,736 | 162,754 | ||||||
| Current liabilities of discontinued operations | 62,030 | 47,538 | ||||||
| Total current liabilities | 577,476 | 463,588 | ||||||
| Long-term deferred revenue | 48,189 | 48,189 | ||||||
| Convertible notes | 328,970 | 152,960 | ||||||
| Operating lease liability | 206,161 | 143,534 | ||||||
| Long-term debt | 116,534 | 137,303 | ||||||
| Long-term debt - related party | 54,850 | 53,538 | ||||||
| Deferred tax liability | 3,524 | 3,758 | ||||||
| Other long-term liabilities | 31,291 | 47,353 | ||||||
| Total liabilities | 1,366,995 | 1,050,223 | ||||||
| Commitments and contingencies | ||||||||
| Redeemable preferred stock | ||||||||
| Series B convertible non-voting preferred stock, | 18,285 | 17,805 | ||||||
| Series B-1 convertible non-voting preferred stock, | 55,210 | 53,710 | ||||||
| Equity: | ||||||||
| Common stock, | 2,806 | 2,663 | ||||||
| Additional paid-in capital | 1,371,216 | 1,358,992 | ||||||
| Accumulated other comprehensive loss | (15,216 | ) | (18,213 | ) | ||||
| Accumulated deficit | (1,157,027 | ) | (1,093,072 | ) | ||||
| Total equity | 201,779 | 250,370 | ||||||
| Total liabilities, redeemable preferred stock and equity | $ | 1,642,269 | $ | 1,372,108 | ||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (In thousands, except per share amounts) (Unaudited) | |||||||||||||||
| Three months ended | Six months ended | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Net sales | $ | — | $ | 66,465 | $ | 241 | $ | 66,465 | |||||||
| Net sales - related party | 250,128 | 66,302 | 427,534 | 119,754 | |||||||||||
| Total net sales | 250,128 | 132,767 | 427,775 | 186,219 | |||||||||||
| Cost of sales | 201,031 | 100,006 | 349,594 | 135,677 | |||||||||||
| Gross profit | 49,097 | 32,761 | 78,181 | 50,542 | |||||||||||
| Operating expenses: | |||||||||||||||
| Selling, general and administrative | 71,878 | 62,712 | 123,467 | 106,091 | |||||||||||
| Impairment of intangible assets | — | 1,410 | — | 1,410 | |||||||||||
| Total operating expenses | 71,878 | 64,122 | 123,467 | 107,501 | |||||||||||
| Operating loss from continuing operations | (22,781 | ) | (31,361 | ) | (45,286 | ) | (56,959 | ) | |||||||
| Other (expense) income: | |||||||||||||||
| Warrant liability fair value adjustment | (2,836 | ) | (220 | ) | 7,577 | 1,347 | |||||||||
| Derivative liabilities fair value adjustment | (5,493 | ) | 1,048 | 14,462 | 26,277 | ||||||||||
| Impairment of assets previously classified as held for sale | — | (1,747 | ) | — | (2,029 | ) | |||||||||
| Interest expense, net | (6,726 | ) | (8,045 | ) | (12,890 | ) | (17,898 | ) | |||||||
| Other income, net | 1,690 | 3,162 | 3,671 | 3,325 | |||||||||||
| Total other (expense) income | (13,365 | ) | (5,802 | ) | 12,820 | 11,022 | |||||||||
| Loss from continuing operations before income taxes | (36,146 | ) | (37,163 | ) | (32,466 | ) | (45,937 | ) | |||||||
| Income tax (expense) benefit | (781 | ) | 5,979 | (559 | ) | 8,492 | |||||||||
| Net loss from continuing operations | (36,927 | ) | (31,184 | ) | (33,025 | ) | (37,445 | ) | |||||||
| Net loss from discontinued operations, net of tax | (6,609 | ) | (725 | ) | (30,930 | ) | (10,703 | ) | |||||||
| Net loss | (43,536 | ) | (31,909 | ) | (63,955 | ) | (48,148 | ) | |||||||
| Preferred dividends and accretion | (990 | ) | (891 | ) | (1,980 | ) | (1,782 | ) | |||||||
| Net loss attributable to common stockholders | $ | (44,526 | ) | $ | (32,800 | ) | $ | (65,935 | ) | $ | (49,930 | ) | |||
| Weighted average shares outstanding: | |||||||||||||||
| Weighted average shares of common stock outstanding - basic | 280,129 | 155,938 | 279,282 | 155,936 | |||||||||||
| Weighted average shares of common stock outstanding - diluted | 280,129 | 155,938 | 279,282 | 155,936 | |||||||||||
| Net loss per share attributable to common stockholders: | |||||||||||||||
| Net loss per share from continuing operations - basic and diluted | $ | (0.14 | ) | $ | (0.21 | ) | $ | (0.13 | ) | $ | (0.25 | ) | |||
| Net loss per share from discontinued operations - basic and diluted | $ | (0.02 | ) | $ | — | $ | (0.11 | ) | $ | (0.07 | ) | ||||
| Net loss per share - basic and diluted | $ | (0.16 | ) | $ | (0.21 | ) | $ | (0.24 | ) | $ | (0.32 | ) | |||
| Other comprehensive loss: | |||||||||||||||
| Net loss | $ | (43,536 | ) | $ | (31,909 | ) | $ | (63,955 | ) | $ | (48,148 | ) | |||
| Foreign currency translation adjustments | (4,341 | ) | 13,482 | 2,997 | 39,547 | ||||||||||
| Total comprehensive loss | (47,877 | ) | (18,427 | ) | (60,958 | ) | (8,601 | ) | |||||||
| Preferred dividends and accretion | (990 | ) | (891 | ) | (1,980 | ) | (1,782 | ) | |||||||
| Comprehensive loss attributable to common stockholders | $ | (48,867 | ) | $ | (19,318 | ) | $ | (62,938 | ) | $ | (10,383 | ) | |||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) (Unaudited) | ||||||||
| Six months ended | ||||||||
| 2026 | 2025 | |||||||
| Cash flows from operating activities: | ||||||||
| Net loss | $ | (63,955 | ) | $ | (48,148 | ) | ||
| Adjustments to reconcile net loss to cash used in operating activities: | ||||||||
| Share-based compensation expense | 8,530 | 5,220 | ||||||
| Depreciation and amortization | 50,121 | 43,598 | ||||||
| Impairment of intangible assets | — | 1,410 | ||||||
| Impairment of assets previously classified as held for sale | — | 2,029 | ||||||
| Change in valuation allowance | 15,358 | (2,230 | ) | |||||
| Change in fair value of derivative liabilities | (14,462 | ) | (26,277 | ) | ||||
| Gain on sale of property and equipment | — | (5,675 | ) | |||||
| Amortization of debt issuance costs, premium and discount | 3,745 | 7,923 | ||||||
| Reduction in the carrying amount of right-of-use assets | 4,747 | 3,259 | ||||||
| Warrant liability fair value adjustment | (7,577 | ) | (1,347 | ) | ||||
| Deferred income taxes | (234 | ) | (6,994 | ) | ||||
| Other | (89 | ) | 2,349 | |||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable trade | (14,164 | ) | (34,584 | ) | ||||
| Government grants receivable, net | (59,014 | ) | (43,970 | ) | ||||
| Inventory | (112,730 | ) | (51,673 | ) | ||||
| Other assets | (1,296 | ) | — | |||||
| Advances to suppliers and other current assets | (31,236 | ) | 29,904 | |||||
| Accounts payable, accrued liabilities and other | 25,610 | 75,035 | ||||||
| Deferred revenue | 93,667 | 38,788 | ||||||
| Net cash used in operating activities | (102,979 | ) | (11,383 | ) | ||||
| Cash flows from investing activities: | ||||||||
| Issuance of notes receivable | (8,594 | ) | — | |||||
| Proceeds from the return of property and equipment deposits | — | 1,202 | ||||||
| Purchases of property and equipment | (161,821 | ) | (51,943 | ) | ||||
| Proceeds from the sale of property and equipment | — | 50,000 | ||||||
| Net cash used in investing activities | (170,415 | ) | (741 | ) | ||||
| Cash flows from financing activities: | ||||||||
| Repayment of Senior Secured Credit Facility | (18,764 | ) | (14,874 | ) | ||||
| Proceeds from issuance of Convertible Notes, net of underwriting fees | 175,720 | — | ||||||
| Exercise of Penny Warrants | 70 | — | ||||||
| Payment of debt issuance costs | (912 | ) | (3,760 | ) | ||||
| Exercise of stock options | 6,833 | — | ||||||
| Cash paid for equity repurchases for equity-based compensation tax withholding | (3,818 | ) | — | |||||
| Net cash (used in) provided by financing activities | 159,129 | (18,634 | ) | |||||
| Effect of changes in foreign exchange rates on cash, cash equivalents, and restricted cash | (72 | ) | 777 | |||||
| Net decrease in cash, cash equivalents, and restricted cash | (114,337 | ) | (29,981 | ) | ||||
| Cash, cash equivalents, and restricted cash at beginning of period | 270,773 | 76,645 | ||||||
| Cash, cash equivalents, and restricted cash at end of period | $ | 156,436 | $ | 46,664 | ||||
| Reconciliation to condensed consolidated balance sheets: | ||||||||
| Cash and cash equivalents | $ | 79,109 | $ | 8,451 | ||||
| Restricted cash | 77,327 | 38,213 | ||||||
| Cash, cash equivalents, and restricted cash | $ | 156,436 | $ | 46,664 | ||||
RECONCILIATION OF NON-GAAP MEASURES TO MOST COMPARABLE AMOUNTS (In thousands) (Unaudited) | ||||||||||||||||
| Three months ended | Six months ended | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Net loss (1) | $ | (43,536 | ) | $ | (31,909 | ) | $ | (63,955 | ) | $ | (48,148 | ) | ||||
| Net loss from discontinued operations, net of tax | 6,609 | 725 | 30,930 | 10,703 | ||||||||||||
| Net loss from continuing operations (1) | (36,927 | ) | (31,184 | ) | (33,025 | ) | (37,445 | ) | ||||||||
| Adjustments to net income (loss) from continuing operations | ||||||||||||||||
| Interest expense, net | 6,726 | 8,045 | 12,890 | 17,898 | ||||||||||||
| Income tax benefit | 781 | (5,979 | ) | 559 | (8,492 | ) | ||||||||||
| Depreciation and amortization | 25,016 | 28,920 | 50,121 | 43,598 | ||||||||||||
| Impairment of assets previously classified as held for sale | — | 1,747 | — | 2,029 | ||||||||||||
| Warrant liability fair value adjustment | 2,836 | 220 | (7,577 | ) | (1,347 | ) | ||||||||||
| Derivative liabilities fair value adjustment | 5,493 | (1,048 | ) | (14,462 | ) | (26,277 | ) | |||||||||
| Other income, net | (1,690 | ) | (3,162 | ) | (3,671 | ) | (3,325 | ) | ||||||||
| Share-based compensation expense | 5,792 | 1,281 | 8,530 | 5,220 | ||||||||||||
| Transaction and nonrecurring expenses (2) | 2,630 | 1,829 | 6,426 | 4,809 | ||||||||||||
| Adjusted EBITDA (1) | $ | 10,657 | $ | 669 | $ | 19,791 | $ | (3,332 | ) | |||||||
(1) Net loss, Net loss from continuing operations and Adjusted EBITDA include pre-tax reduction in Cost of sales due to
(2) Transaction and nonrecurring expenses includes
Source: 